| 1 |
33251975 | Combination of QSAR, molecular docking, molecular dynamic simulation and MM-PBSA: analogues of lopinavir and favipiravir as potential drug candidates against COVID-19. | 2022 May |
2 |
| 2 |
33992054 | Structural Basis for the Understanding of Entry Inhibitors against SARS Viruses. | 2022 |
1 |
| 3 |
35185356 | Insight into the biological impact of COVID-19 and its vaccines on human health. | 2022 May |
2 |
| 4 |
35430987 | Favipiravir in SARS-CoV-2 infection: Is it Worthwhile? | 2022 Apr 14 |
1 |
| 5 |
32338164 | SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective. | 2021 Jun |
1 |
| 6 |
32783586 | New anti-viral drugs for the treatment of COVID-19 instead of favipiravir. | 2021 Nov |
2 |
| 7 |
33176643 | Computational Evidences of Phytochemical Mediated Disruption of PLpro Driven Replication of SARS-CoV-2: A Therapeutic Approach against COVID-19. | 2021 |
1 |
| 8 |
33347311 | Overview of Targets and Potential Drugs of SARS-CoV-2 According to the Viral Replication. | 2021 Jan 1 |
1 |
| 9 |
33556871 | An update review of emerging small-molecule therapeutic options for COVID-19. | 2021 May |
1 |
| 10 |
33693066 | Structural analogues of existing anti-viral drugs inhibit SARS-CoV-2 RNA dependent RNA polymerase: A computational hierarchical investigation. | 2021 Mar |
1 |
| 11 |
33815808 | Computational insights of phytochemical-driven disruption of RNA-dependent RNA polymerase-mediated replication of coronavirus: a strategic treatment plan against coronavirus disease 2019. | 2021 May |
1 |
| 12 |
34136511 | Bioactive Molecules of Tea as Potential Inhibitors for RNA-Dependent RNA Polymerase of SARS-CoV-2. | 2021 |
1 |
| 13 |
34247016 | Cyanorona-20: The first potent anti-SARS-CoV-2 agent. | 2021 Sep |
1 |
| 14 |
34339634 | "Bucket brigade" using lysine residues in RNA-dependent RNA polymerase of SARS-CoV-2. | 2021 Sep 7 |
2 |
| 15 |
34409597 | Interface-based design of the favipiravir-binding site in SARS-CoV-2 RNA-dependent RNA polymerase reveals mutations conferring resistance to chain termination. | 2021 Sep |
4 |
| 16 |
34717229 | Potential of turmeric-derived compounds against RNA-dependent RNA polymerase of SARS-CoV-2: An in-silico approach. | 2021 Dec |
1 |
| 17 |
34829734 | Potential of Marine Terpenoids against SARS-CoV-2: An In Silico Drug Development Approach. | 2021 Oct 20 |
1 |
| 18 |
34873274 | Comparative assessment of favipiravir and remdesivir against human coronavirus NL63 in molecular docking and cell culture models. | 2021 Dec 6 |
1 |
| 19 |
34881025 | Understanding the clinical utility of favipiravir (T-705) in coronavirus disease of 2019: a review. | 2021 Jan-Dec |
1 |
| 20 |
32246834 | Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019-nCoV Infection. | 2020 Aug |
1 |
| 21 |
32392072 | Novel Coronavirus Polymerase and Nucleotidyl-Transferase Structures: Potential to Target New Outbreaks. | 2020 Jun 4 |
1 |